Vanguard Group’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$439M Sell
3,605,279
-328
-0% -$41.2K 0.01% 1137
2025
Q3
$405M Buy
3,605,607
+9,650
+0.3% +$1.13M 0.01% 1178
2025
Q2
$482M Buy
3,595,957
+20,961
+0.6% +$2.3M 0.01% 1048
2025
Q1
$241M Sell
3,574,996
-60,923
-2% -$4.19M ﹤0.01% 1396
2024
Q4
$227M Buy
3,635,919
+40,860
+1% +$3.8M ﹤0.01% 1489
2024
Q3
$564M Buy
3,595,059
+1,068,659
+42% +$165M 0.01% 965
2024
Q2
$381M Buy
2,526,400
+637,306
+34% +$76.4M 0.01% 1125
2024
Q1
$140M Buy
1,889,094
+23,979
+1% +$1.98M ﹤0.01% 1695
2023
Q4
$147M Buy
1,865,115
+50,673
+3% +$3.06M ﹤0.01% 1670
2023
Q3
$99.3M Buy
1,814,442
+29,798
+2% +$2.14M ﹤0.01% 1814
2023
Q2
$150M Buy
1,784,644
+66,388
+4% +$5.08M ﹤0.01% 1626
2023
Q1
$130M Buy
1,718,256
+26,831
+2% +$1.86M ﹤0.01% 1687
2022
Q4
$104M Buy
1,691,425
+46,734
+3% +$2.48M ﹤0.01% 1785
2022
Q3
$68.7M Buy
1,644,691
+208,377
+15% +$9.06M ﹤0.01% 2017
2022
Q2
$45.2M Buy
1,436,314
+109,408
+8% +$2.92M ﹤0.01% 2244
2022
Q1
$35.7M Sell
1,326,906
-3,613
-0.3% -$64.7K ﹤0.01% 2470
2021
Q4
$25.5M Buy
1,330,519
+68,288
+5% +$1.71M ﹤0.01% 2711
2021
Q3
$41.8M Buy
1,262,231
+33,453
+3% +$1.02M ﹤0.01% 2457
2021
Q2
$40.8M Buy
1,228,778
+15,783
+1% +$437K ﹤0.01% 2478
2021
Q1
$50.3M Buy
1,212,995
+54,528
+5% +$1.68M ﹤0.01% 2315
2020
Q4
$23.1M Buy
1,158,467
+31,540
+3% +$467K ﹤0.01% 2562
2020
Q3
$15.5M Buy
1,126,927
+260,899
+30% +$4.47M ﹤0.01% 2573
2020
Q2
$15.5M Buy
866,028
+193,645
+29% +$3.03M ﹤0.01% 2548
2020
Q1
$8.12M Buy
672,383
+18,103
+3% +$303K ﹤0.01% 2708
2019
Q4
$12.4M Buy
654,280
+301,818
+86% +$5.54M ﹤0.01% 2751
2019
Q3
$8.37M Buy
352,462
+43,503
+14% +$1.04M ﹤0.01% 2909
2019
Q2
$8.96M Buy
+308,959
New +$8.43M ﹤0.01% 2919

Other funds holding TMDX